{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05559853",
            "orgStudyIdInfo": {
                "id": "22-191"
            },
            "organization": {
                "fullName": "Memorial Sloan Kettering Cancer Center",
                "class": "OTHER"
            },
            "briefTitle": "Developing a New MRI Technique to Understand Changes in Brain Tumors After Treatment",
            "officialTitle": "Development of a Clinical CEST MR Fingerprinting Method for Treatment Response Assessment in Brain Metastases",
            "therapeuticArea": [
                "Oncology and Hematology",
                "Other"
            ],
            "study": "developing-a-new-mri-technique-to-understand-changes-in-brain-tumors-after-treatment"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-06",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2022-09-22",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2027-09-22",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2027-09-22",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-09-22",
            "studyFirstSubmitQcDate": "2022-09-27",
            "studyFirstPostDateStruct": {
                "date": "2022-09-29",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-06-05",
            "lastUpdatePostDateStruct": {
                "date": "2024-06-07",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Memorial Sloan Kettering Cancer Center",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": true
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this study is to develop and test a new magnetic resonance imaging (MRI) technique to see if it can be used to tell the difference between tumor growth from worsening of cancer and growth from the effects of treatment in participants who have brain tumors treated with radiation therapy called stereotactic radiosurgery (SRS)."
        },
        "conditionsModule": {
            "conditions": [
                "Brain Metastases",
                "Brain Metastases, Adult",
                "Metastatic Brain Tumor",
                "Metastatic Brain Cancer"
            ],
            "keywords": [
                "Brain Metastases",
                "Healthy Volunteers",
                "metastatic brain tumor",
                "metastatic brain cancer",
                "Brain Metastases, Adult",
                "MRI",
                "untreated brain metastasis",
                "CEST-MRF",
                "chemical exchange saturation transfer magnetic resonance fingerprinting",
                "22-191",
                "Memorial Sloan Kettering Cancer Center"
            ]
        },
        "designModule": {
            "studyType": "OBSERVATIONAL",
            "patientRegistry": false,
            "designInfo": {
                "observationalModel": "CASE_CONTROL",
                "timePerspective": "PROSPECTIVE"
            },
            "enrollmentInfo": {
                "count": 94,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Participants with Brain Metastases",
                    "description": "Participants will have at least one untreated brain metastasis \\> 1cm",
                    "interventionNames": [
                        "Diagnostic Test: CEST-MRF"
                    ]
                },
                {
                    "label": "Healthy participants",
                    "description": "Participants will have no known cancer diagnosis. Volunteers enrolled on this protocol may undergo multiple MRI examinations periodically for studies of reproducibility.",
                    "interventionNames": [
                        "Diagnostic Test: CEST-MRF"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DIAGNOSTIC_TEST",
                    "name": "CEST-MRF",
                    "description": "CEST-MRF enables accurate quantification of both proton exchange rates and volume fractions in a fraction of the time required by conventional pulse sequences will be developed and optimized.",
                    "armGroupLabels": [
                        "Healthy participants",
                        "Participants with Brain Metastases"
                    ],
                    "otherNames": [
                        "chemical exchange saturation transfer magnetic resonance fingerprinting method"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Change of Rapid chemical exchange saturation transfer (CEST) imaging with magnetic resonance fingerprinting (MRF)/CEST-MRF parameters with and without motion",
                    "description": "Develop a rapid and robust 3D CEST-MRF pulse sequence for clinical scanners using our preclinical CEST-MRF pulse sequence as a basis by evaluating the changes of the 6 CEST-MRF parameters with and without motion. These parameters include the water T1 and T2 relaxation (T1w,T2w), amide exchange rate (ksw) and volume fraction (fs) and the semi-solid exchange rate (kssw) and volume fraction (fss).",
                    "timeFrame": "Up to 3 years"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\nHealthy volunteers \\[for Study Aim 1 (SA1)\\] will be entered into the study if they meet the following criteria:\n\n* Age \u2265 18 years\n* Able to understand and give informed consent\n* No known cancer diagnosis\n\nPatients \\[for Study Aim 3 (SA3)\\] will be entered into the study if they meet the following criteria:\n\n* Age \u2265 18 years\n* Able to understand and give informed consent\n* At least one untreated brain metastasis \\> 1cm (e.g., an enhancing lesion in the brain of a patient with known systemic cancer determined likely to represent metastasis by neuroradiologist)\n* Planned SRS treatment\n\nExclusion Criteria:\n\nHealthy volunteers (SA1) and patients (SA2) exclusion criteria:\n\n* Pregnant or breastfeeding women\n* Pre-existing medical conditions, including the likelihood of developing seizures or claustrophobic reactions, and any greater than normal potential for cardiac arrest\n* Age \\< 18 years",
            "healthyVolunteers": true,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ],
            "studyPopulation": "The study investigators will discuss participant potentially eligible for research participation within their interdisciplinary brain metastasis disease management team. These potential participants will then be contacted by their treating physician or investigator team. Study investigators will prioritize consenting participants who are planned to undergo SRS and, when possible, will attempt to coordinate the research scan with their clinically necessary MRI scans to minimize time and disruption for the participant.",
            "samplingMethod": "NON_PROBABILITY_SAMPLE"
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Ouri Cohen, PhD",
                    "role": "CONTACT",
                    "phone": "646-608-8259",
                    "email": "coheno1@mskcc.org"
                },
                {
                    "name": "Nelson Moss, MD",
                    "role": "CONTACT",
                    "phone": "212-639-7075",
                    "email": "mossn@mskcc.org"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Ouri Cohen, PhD",
                    "affiliation": "Memorial Sloan Kettering Cancer Center",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Memorial Sloan Kettering Cancer Center (All Protocol Activities)",
                    "status": "RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10065",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Ouri Coheb, PhD",
                            "role": "CONTACT",
                            "phone": "646-608-8259"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                }
            ]
        },
        "referencesModule": {
            "seeAlsoLinks": [
                {
                    "label": "Memorial Sloan Kettering Cancer Center",
                    "url": "http://www.mskcc.org"
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "Memorial Sloan Kettering Cancer Center supports the international committee of medical journal editors (ICMJE) and the ethical obligation of responsible sharing of data from clinical trials. The protocol summary, a statistical summary, and informed consent form will be made available on clinicaltrials.gov when required as a condition of Federal awards, other agreements supporting the research and/or as otherwise required. Requests for deidentified individual participant data can be made beginning 12 months after publication and for up to 36 months post publication. Deidentified individual participant data reported in the manuscript will be shared under the terms of a Data Use Agreement and may only be used for approved proposals. Requests may be made to: crdatashare@mskcc.org."
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000009362",
                    "term": "Neoplasm Metastasis"
                },
                {
                    "id": "D000016609",
                    "term": "Neoplasms, Second Primary"
                },
                {
                    "id": "D000001932",
                    "term": "Brain Neoplasms"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009385",
                    "term": "Neoplastic Processes"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                },
                {
                    "id": "D000016543",
                    "term": "Central Nervous System Neoplasms"
                },
                {
                    "id": "D000009423",
                    "term": "Nervous System Neoplasms"
                },
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000001927",
                    "term": "Brain Diseases"
                },
                {
                    "id": "D000002493",
                    "term": "Central Nervous System Diseases"
                },
                {
                    "id": "D000009422",
                    "term": "Nervous System Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M12307",
                    "name": "Neoplasm Metastasis",
                    "asFound": "Metastases",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5209",
                    "name": "Brain Neoplasms",
                    "asFound": "Brain Metastases",
                    "relevance": "HIGH"
                },
                {
                    "id": "M18989",
                    "name": "Neoplasms, Second Primary",
                    "asFound": "Metastases",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12330",
                    "name": "Neoplastic Processes",
                    "relevance": "LOW"
                },
                {
                    "id": "M18937",
                    "name": "Central Nervous System Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M12367",
                    "name": "Nervous System Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M5204",
                    "name": "Brain Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M5742",
                    "name": "Central Nervous System Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                }
            ]
        }
    },
    "hasResults": false
}